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Ambulatory clinical healthcare settings that serve patients infected with the 
human immunodeficiency virus (HIV) are critical in improving access to quality 
HIV care and treatment, in part due to their ability to streamline patient care 
along the HIV care continuum. Barriers to HIV care are significant among newly 
diagnosed HIV patients and in order to engage and retain these individuals in 
care and treatment, specific interventions must be in place to link these 
individuals to care. In this study, the difference in differences method was used 
for data analysis to measure the impact of an ambulatory clinics intervention on 
their newly diagnosed HIV patients in an effort to improve their retention in care 
and HIV viral load suppression. The study participants all received their HIV 
specific care and treatment solely at the University of Kentucky, Department of 
Infectious Diseases HIV/AIDS Clinical Program (IMDP) that is a Ryan White 
HIV/AIDS program funded ambulatory clinic. Of the 1,156 patients enrolled in the 
IMDP clinic during the study, only 178 met the criteria for inclusion in the study. 
This retrospective cohort study included data extracted from 178 patients’ 
electronic health records over a 24-month period, with 96 patients in the first 12-
month cohort and 82 patients in the second 12-month cohort. The differences in 
means from the two data sets were analyzed for significance using the 
Kolmogorov Smirnov two-sample test (KS) and p-value. The length of time 
between readings of the biomarkers viral load and CD4+ T-lymphocyte cell count 
at attended provider visits was statistically significant, suggesting that clients 
exposed to the intervention with these readings less than 90 days apart were 
more likely to have the recommended number of provider visits in a 12-month 
period more than 90 days apart. No significant differences in visit spacing means 
were found when controlling for viral load or CD4+ T-lymphocyte cell count. 
Additionally, each cohort’s mean differences showed a positive trend towards 
decreased viral load and increased CD4+ T-Lymphocyte cell count. Overall, this 
study provided empirical evidence for more consideration towards implementing 
HIV clinical interventions within large ambulatory clinical health systems that 
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Individuals infected with the human immunodeficiency virus (HIV) are living 
longer and experiencing improved quality of life due to scientific innovations in 
antiretroviral therapy, and, as a result, they are achieving viral load suppression 
sooner, which significantly reduces the risk of transmitting the disease (Doshi, 
2015). Despite these scientific advances, over a million individuals in the U.S. are 
living with HIV and only one in eight know that they are infected (Centers for 
Disease Control and Prevention, Health Resources and Service Administration, 
2014). Data from the Centers for Disease Control and Prevention (CDC), 
displayed in Figure A, estimates that only 66 percent of individuals living in the 
US diagnosed with HIV were linked to HIV care, and of those, only 25 percent 
ever achieved viral load suppression (Centers for Disease Control and 
Prevention, Health Resources and Service Administration, 2014). These 
alarming statistics have garnered the attention of national government leaders, 
healthcare facilities that offer HIV care, and healthcare providers. Consequently, 
in 2010, President Barack Obama and his administration released the National 
HIV/AIDS Strategy for the United States. The strategy seeks to reduce the 
incidence rates of HIV, improve health outcomes for those living with HIV, reduce 
disparities and inequities in healthcare for HIV care and treatment, and provide 
healthcare facilities and providers a framework to move patients along the HIV 
continuum of care (The Office of National AIDS Policy, 2015). The HIV Care 
Continuum (Figure B) was established through an executive order by President 
Barack Obama in 2013  and directed federal departments to prioritize  increasing 
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the number of individuals tested, diagnosed, linked and engaged in care, actively 
on antiretroviral therapy, and achieving viral load suppression while implementing  
(The White House Office of National AIDS Policy Executive Order, 2013). 
Evidence suggests that an approach similar to that outlined in the HIV Care 
Continuum may be an effective means to deliver services related to HIV 
(Gardner E. M., 2011).  
Retention in care, although challenging, is a critical step in the HIV continuum of 
care and supports the patient achieving the desired outcome of viral load 
suppression, and initiation of antiretroviral therapy (Mugavero & et.al., 2011). The 
CDC defines it as the process of assisting persons with HIV to attend scheduled 
follow-up HIV medical appointments after they have started HIV medical care 
(Centers for Disease Control and Prevention, Health Resources and Service 
Administration, 2014). The Institute of Medicine defines clinical recommendations 
for retention outcomes as the patient attending two HIV medical visits with in one 
year at least 90 days apart following new HIV diagnosis (Institute of Medicine of 
the National Academies, 2012).  
Ambulatory clinical settings provide a critical access point to take advantage of 
the time interval between a patient’s HIV diagnosis and the initiation of 
antiretroviral therapy (Irvine, 2015). This study used data from 178 newly 
diagnosed HIV patients ages 18-64, enrolled in a Ryan White HIV/AIDS program 
(RWHAP) funded clinic in a large, urban, academic medical center 
retrospectively followed over a 24 month period, to examine the impact of an 
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retention in HIV care intervention on HIV biomarkers and the time periods 





Study Design Overview 
In this retrospective cohort study, data was collected from electronic medical 
records of 178 newly diagnosed HIV patients enrolled in University of Kentucky 
Department of Infectious Diseases HIV/AIDS Clinical Program (IMDP) which is 
part of the University of Kentucky Healthcare system in Lexington, KY. Data from 
the first cohort of patients, labeled Group A, was collected during a 12-month 
period from June 1, 2013 through May 31, 2014. Data from the second cohort of 
patients, labeled Group B, was collected from June 1, 2014 through May 31, 
2015. In a response to improving their performance measures and attempting to 
meet the recommended clinical guidelines for HIV Care by the National Health 
Resources and Services Administration (HRSA), HIV/ AIDS Bureau, the clinic’s 
continuous quality management (CQM) team developed an intervention. The 
multifaceted intervention for a 12-month period involved linking individuals to 
other medical and social support services, multiple case management sessions, 
navigation assistance for enrolling on health insurance, and transportation 
services to IMDP clinic provider visits. Group B was the only group exposed to 
the intervention. The CQM team closely monitored every encounter with a patient 
using an Excel spreadsheet to document each client’s date and attendance at 
IMDP clinic provider visits, frequency of medical case management services 
provided, and appointment reminders. Each patient from Group B was assigned 
 8 
to one CQM team clinical social worker (CSW), who managed the case 
beginning at the patient’s initial visit to the IMDP clinic. 
 
Study Population 
Patients were referred to the IMDP clinic by an outside agency, hospital inpatient 
follow-up for HIV specific care, or self-referral resulting from an inconclusive or 
positive HIV-1 RNA oral antibody test. The IMDP clinic only serves clients who 
live within its 68 county region, which includes majority of the counties on the 
eastern half of the state of Kentucky (Figure C). The data included all newly 
diagnosed HIV patients that were treatment naïve for antiretroviral therapy during 
the period of June 1, 2013 through May 31, 2015.  
Study inclusion criteria were: at least one new patient intake visit at the IMDP 
clinic, blood serum confirmed HIV infection laboratory test, treatment naïve for 
antiretroviral therapy, aged 18 to 64 years old,  not pregnant and did not become 
pregnant, die, discharge to palliative care, or become imprisoned during the 
study period. Data elements included demographic information (Table 1); 
attendance at all regularly scheduled provider visits at IMDP clinic, and recorded 
labs results of every blood serum test for HIV viral load and CD4+ T-lymphocyte 
cell count at each HIV provider visit. The IMDP clinic’s intervention included 
improving the frequency of communication for newly diagnosed HIV patients in 
an effort to improve their retention rates. The intervention increased the 
frequency of CSW encounters for case management and in-person contacts for 
appointment reminders. Criteria for encounters included the CSW’s facilitation of 
any additional medical or support services (Table 5). Criteria for in-person 
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contacts for appointment reminders included direct contact with the patient 
through phone, email, or in-person at least one week before any scheduled 
provider visit and follow-up for missed appointments at the IMDP clinic.  
Patients’ electronic medical records were individually reviewed if the patient was 
not retained in care (definition below) due to a self-reported move out of IMDP 
service area, death, discharge to prison, or discharge to palliative care. If the 
date of any of these incidents occurred during the study then the patient was 
excluded from analysis of the data from that date forward.  
 
 
Exposures and Outcomes  
For the purpose of this study, the Institute of Medicines (IOM) standards for HIV 
care were indexed to analyze the impact of the intervention on the outcomes for 
retention in care, viral load suppression, and improved CD4+ T-lymphocyte cell 
count. IOM defines, retention in care for newly diagnosed HIV patients, as 
attending an infectious disease provider visit three times, at least 90 days apart, 
in a 12-month period (Institute of Medicine of the National Academies, 2012). 
The IMDP clinic’s protocol and procedures for clinical HIV care states that for 
each provider visit ≥90 days apart that the provider order routine HIV labs for HIV 
viral load and CD4+ T-lymphocyte cell count either the same date as provider 
visit or one week before scheduled provider visit. A patient’s medical record with 
at least three attended provider visits, ≥90 days apart during the study were 
considered retained in care. If the patient’s medical record reported less than two 
provider visits, ≥ 90 days apart they were not considered as retained in care.  
When controlling for viral load and CD4+ T-lymphocyte cell count the duration of 
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time between attended provider visits was analyzed to illustrate the impact of the 
intervention on retention in care. Thus supporting how critical the time between 
attended provider visits may affect retention in care and the patient’s progress 
towards viral load suppression and improved immune system. Viral load 
suppression and improved CD4+ T-lymphocyte are key biomarkers expressing 
the impact of the intervention on retention in care (Doshi, 2015). 
Viral load suppression as defined by IOM is a blood serum HIV-1 RNA viral load 
less than or equal to 200 copies/mL each patient-year (Institute of Medicine of 
the National Academies, 2012). The patient’s plasma HIV viral load and CD4+ T-
lymphocyte cell count was recorded at each of these, as well as the baseline 
values ≥90 days from their first IMDP clinic intake visit and when the patient 
started anti-retroviral therapy. Patients with blood serum HIV viral loads ≤200 
copies/mL were characterized as virally suppressed and assigned a value of 200 
copies/mL for data analysis (Mugarvero, 2014). HIV viral loads greater than 
10,000,000 copies were assigned to upper limit quantification of 10,000,000 
copies per/mL. If a no viral load data was available for a patient during each 12-
month period, the patient was considered to have a viral load greater than 200 
copies/mL and therefore were not considered virally suppressed based on the 
IOM standards. If the patients’ medical records did not report at least two viral 
load readings during the 12 month period, the patient was defined as not virally 
suppressed and was recorded to have an HIV viral load greater than 200 
copies/mL during the 12-month period. 
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For further analysis of viral load suppression, the study captured each CD4+ T-
lymphocyte cell count test ordered at every IMDP clinic provider visits. The CD4+ 
T-lymphocyte cell count is a biometric measure to gauge the improvement of the 
patient’s immune system during first 12 months of care following new HIV 
diagnosis. Patients with CD4+ T-lymphocyte cell count levels ≤200 cell/ mmᶟ 
given a value of 200 cells/mmᶟ for data analysis purposes (U.S. Department for 
Human and Health Services: HIV/AIDS Bureau, 2016). Any Improved CD4+ T-
lymphocyte cell count reading greater than initial IMDP visit reading supports 
viral load suppression and the impact of antiretroviral therapy for patients 
retained in care (Mugavero M. R., 2012). 
Statistical Analysis 
Categorical data was analyzed using Kolmogorov Smirnov two-sample test (KS) 
and p-values were computed. SAS software developed by SAS institute was 
used to perform statistical computations using the difference in differences 
method (DiD) to compare the difference in means for Groups A and Group B. 
The primary outcome variables were viral load suppression, improved CD4+ T-
lymphocyte cell count, and time between readings for viral load and CD4+ T-
lymphocyte cell count. Multivariate and univariate logistic regression analysis 
were performed at the end of the 12-month period for each cohort.   
Experimental studies can underestimate critical factors that vary across times 
and geographical statistics in order to identify casual effects of alternative 
policies or interventions (Stuart, 2014). The DiD method aids in identifying these 
causal effects by contrasting the change in outcomes pre- and post- exposure to 
an intervention for a reference group and a comparison group. The method 
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assumes that without exposure to the intervention the average outcomes of the 
comparison group and the reference group would result in equivalent trends over 
time. The difference-in-differences method (DiD) was used to analyze the 
significance of the IMDP clinic’s recent intervention to improve its retention rate. 
Analysis of both cohorts’ differences in means for viral load readings, CD4 T-
lymphocyte cell count readings, and duration of time between provider 
appointments was calculated using the KS two sample test. The p-value 
generated from this KS analysis was evaluated to determine significance for 
each outcome and specific period.  
RESULTS  
The study included 178 newly diagnosed HIV patients ages 18 to 64 who started 
their HIV care and antiretroviral treatment at the IMDP clinic between June 1, 
2013 and May 31, 2015. Gender at birth was 85 percent (n=151) male and 15 
percent (n=27) female. Regarding HIV risk factors, 70 percent reported being 
men having sex with other men, while eighteen percent reported their risk factor 
as heterosexual exposure. Intravenous drug use (IDU) was, reported as a risk 
factor by 2.25 percent, while another 2.25 percent reported two risk factors being 
both as men who have sex with men and engage in IDU. The remaining 7.5 
percent of risk factors were unknown or due to exposure to infected blood or 
blood components. Furthermore, 75 percent of the full sample was white non-
Hispanic individuals, 15 percent Black/African American, 6 percent Hispanic or 
Latino origin, and 4 percent other or unknown race/ethnicity. In addition,  at the 
time of the patient’s intake visit, 60 percent of the full sample had income levels 
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below 100 percent of the federal  poverty level, 15 percent had no medical 
insurance, and 50 percent of the full sample were actively enrolled in the 
Kentucky Medicaid program as their primary source of medical insurance (Table 
1).   
Multivariate data analysis of CD4+ T-lymphocyte cell count and HIV viral load 
using the difference in differences method found no significant difference 
between Group A and Group B (Tables 2, 3). However,  analysis of the duration 
of time between readings of viral load and CD4+ T-lymphocyte cell count 
combined found a significant difference between the Group A and Group B for 
the first reading to the second reading (diff. 2.6, p <.0425) and from the first to 
the third reading (diff. 10.4, p< .0019) (Table 4). Group A and Group B both 
demonstrated trends for improved CD4+ T-lymphocyte cell counts, initiation of 
antiretroviral therapy within 90 days of first reading, and progress towards viral 
load suppression. Group A showed decreased mean viral load only in the first 
and second readings (Table 2). Group B had significantly higher mean CD4+ T-
lymphocyte counts and higher mean viral loads at the time of their initial intake 




Retention in care and viral load suppression are key determinants in mortality 
and morbidity for newly diagnosed HIV patients within the first 12 months 
following diagnosis (Mugavero M. L., 2009). Ambulatory care clinics are the 
front line of access to medical care for newly diagnosed HIV patients and 
critical points of access to antiretroviral therapy (Irvine, 2015). Providing the 
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needed infrastructure to equip ambulatory care clinics to move newly 
diagnosed HIV clients through the HIV continuum of care in the first 12 
months of diagnosis and then long-term is a critical factor in reaching the 
goals and objectives of the U.S. HIV /AIDS strategy and HIV/AIDS prevention 
efforts (Mayer, 2011). The difference in differences analysis provided a 
methodology for analysis of one ambulatory clinic’s intervention to improve 
health outcomes for their newly diagnosed HIV patients. The analysis did not 
find significance  differences between means for  viral load suppression and 
CD4+ T-lymphocyte cell count, but there was a positive trend for both cohorts 
towards expected outcomes of decreased viral load and improved CD4+ cell 
T-lymphocyte cell count, suggesting that other variables may be impacting the 
results. Another method to evaluate significance, such as a McNemar 
comparison with logistic regression analysis, might have different results. 
Because of the complexity of the HIV disease, it is often difficult to evaluate 
interventions using randomized controlled trials (Gardner, 2014). The 
difference-in-differences method allowed for before-and-after analysis of the 
differences in means for this intervention in an ambulatory setting, similar to 
those often found in large urban or academic medical campus healthcare 
systems. Although for this study, the method may not have been as effective 
in identifying significant differences between the means from Group A and 
Group B, the desired outcomes for decreased viral load and improved CD4+ 
T-lymphocyte cell count showed positive trends over each 12-month period.  
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A poor retention in care rate is an important indicator that the patient is not 
progressing along the HIV continuum of care (Giordano, 2007). Although 
challenging, retention in care for newly diagnosed HIV patients improves 
quality of life, CD4+ T-lymphocyte cell count, the likelihood the patient will 
receive the maximum benefits of antiretroviral therapy, and the patient’s 
progress towards achieving viral load suppression (Centers for Disease 
Control and Prevention, Health Resources and Service Administration, 2014). 
It is imperative to find more interventions that fill the gaps in HIV delivery of 
care and support ambulatory clinics with evidence-based practices that 
progress newly diagnosed HIV patients along the HIV continuum of care 
within the first 12 months of diagnosis.  
Limitations of the study  
This study has several limitations. First, it is a retrospective cohort study of a 
single ambulatory clinic, which limits the generalizability of its findings to other 
HIV populations. The IMDP clinic is one of six RWHAP-funded ambulatory 
clinics in Kentucky, and further research on retention in care and viral load 
suppression for newly diagnosed clients from other ambulatory clinics in 
Kentucky and other states could add to the study’s findings. A second 
limitation is that the study could have missed patients that moved out of the 
IMDP service area during the study. Thirdly, missing viral load data during 
each 12-month period was recorded as not being virally suppressed when in 
fact the patient could have achieved viral load suppression during the study. 
Fourth, because the clinic receives patients on a referral basis for Kentuckians 
who live in its region, the clients who were self-referred or had a partner who 
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receives HIV care at the clinic may have been more motivated to stay 
engaged in care at the IMDP clinic. This limitation could influence the results 
for retention in care, viral load, and CD4+ T-lymphocyte cell count. Finally, the 
lack of control for data from the CSW encounters and personal contacts 
provided to Group B may have given rise to an undetected correlation 
between specific types of encounters and their impact on retention in care and 
viral load suppression. 
Future Direction and Research 
HIV is a complex long-term illness that requires innovative and effective 
strategies to improve access to care, linkage, retention in care, long-term 
engagement in care, and initiation and continued use of antiretroviral therapy in 
order to produce positive health outcomes in persons living with the disease 
(Marks, 2010). This study presented one organization’s strategies to improve 
retention in care for their newly diagnosed patients. Future research on this data 
could assess the impact of confounding variables such as patient wait times, 
provider availability, demographic statistic, time between scheduled and re-
scheduled appointments, smaller or larger healthcare systems, and the time 
between initiation of antiretroviral therapy and viral load suppression. When the 
third readings were recorded for both groups, there was a declining trend in the 
number of patients with recorded provider visits ≥240 days from initial IMDP clinic 
visit and viral load results. This suggests that several clients might have fallen out 
of care, a finding that deserves further exploratory research in longitudinal 
studies and cross-sectional studies. Longitudinal studies could further research 
by exploring interventions that impact retention in care rates and viral load 
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suppression at 24, 36, 48, or 60 months. Finally, it would be beneficial to study 
interventions that work in different healthcare settings and vulnerable populations 
to address patient-specific barriers to care such as transportation assistance, 
access to medical insurance, HIV stigma, travel distance to clinic, voucher 
incentives, and access to behavioral health services.    
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APPENDIX: Tables and Figures
 
Full Sample Group A Group B
Number of individuals in sample 178 96 82
Age at Intake (mean) 34.4 35.2 33.5
sd 15.6 10.7 19.9
Race/Ethnicity 
white NH 130 69 61
african american NH 28 14 14
asian pacific island NH 5 3 2
hispanic 15 10 5
Gender at Birth
female 27 19 8
male 151 77 74
Risk Factor 
heterosexual 33 18 15
IDU 5 4 1
MSM 125 68 57
MSM+IDU 4 1 3
unknown/undetermined 11 5 6
Percent Federal Poverty Level
100% FPL 111 58 53
133% FPL 3 1 2
150% FPL 5 4 1
185% FPL 5 5 0
200% FPL 10 4 6
300% FPL 9 3 6
400% FPL 5 4 1
>400% FPL 3 2 1
Insurance Coverage
no insurance 27 15 12
Medicaid 89 50 39
BCBS 31 16 15
other types 31 15 16
VARIABLE






Table 2. Method Results for CD4+ T-lymphocyte cell count (uL)
CD4 Levels (mean uL) Full Sample Group A Group B Difference p-value
First Reading 509 505 513 8 0.8735
std.dev 324 333 316
non-missing obs 155 81 74
Second Reading 518 496 541 44 0.3633
std.dev 297 284 310
non-missing obs 149 76 73
Third Reading 561 562 559 -3 0.9592
std.dev 329 361 299
non-missing obs 123 60 63
Change from 1st to 3rd Reading 102 110 94 -16 0.6309
sd 117 175 183
non-missing obs 117 57 60
Viral Load (mean copies/mL)
Full Sample Group A Group B Difference p-value
First Reading 32,615 25,653 41,043 15,390 0.6214
std.dev 188,881 123,932 246,315
non-missing obs 168 92 76
Second Reading 7,584 6,457 8,820 2,364 0.6666
std.dev 33,026 27,684 38,202
non-missing obs 151 79 72
Third Reading 3,216 3,251 3,182 -69 0.9827
std.dev 17,520 15,749 19,208
non-missing obs 122 60 62
Change from 1st-3rd Reading 40,118 34,590 45,556 10,967 0.7861
std.dev 221,765 153,091 274,322
non-missing obs 121 60 61








Full Sample Group A Group B Difference p-value
Intake to 1st reading 14.9 13.6 16.3 2.7 0.1113
sd 10.6 9.2 11.9
non-missing obs 160 84 76
1st reading to 2nd reading 13.1 11.8 14.4 2.6 0.0425
sd 8.1 7.2 8.8
non-missing obs 155 81 74
2nd reading to 3rd reading 17.1 16.3 17.8 1.5 0.4354
sd 11.0 10.7 11.2
non-missing obs 126 62 64
Intake to 3rd reading 41.1 35.8 46.2 10.4 0.0019
sd 18.8 18.0 18.4
non-missing obs 123 61 62
Duration between readings 
(number of weeks)
Table 4. Method Results for duration of time between readings for viral 
Load and CD4+ cell count combined
Referral for Behavioral Health
Referral for State AIDS Drug Assistance Program
Partner Testing and Counseling




Food Bank Agency Referrals
Medication Copay Assistance
Assistance for Durable Medical Equipment
Medical Insurance Premium Assistance
Navigation to enroll in state Health benefit exchange program or Medicaid
Tobacco Cessation Counseling
Substance Abuse Treatment Referral
Medication adherence counseling 








Figure A: 2011 CDC Analysis: The Continuum of Engagement in HIV Care (Centers for 











Figure C. University of Kentucky Department of Infectious Diseases HIV/AIDS 
Clinical Program (IMDP) Service Area Map (University of Kentucky, College of Medicine, 2015) 
Figure B. The Continuum of Engagement in HIV medical care 
(Centers for Disease Control and Prevention, 2014). 
 
 
